Table 4 PIVKA-II and AFP levels in patients with recurrence after transplantation.

From: Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma

Biomarker

Sample

Patient 7

Patient 13

Patient 19

Patient 23

PIVKA-II (mAU/mL)

Before OLT

596

19

725

71

1 month after OLT

17

112

52

33

6 months after OLT

271

45

4780

36

1 year after OLT

–

–

75,000

1915

2 years after OLT

–

–

–

75,000

AFP (ng/mL)

Before OLT

3

253

11

4

1 month after OLT

4

9

2

1

6 months after OLT

93

17

108

2

1 year after OLT

–

–

163

2

2 years after OLT

–

–

–

3

  1. OLT orthotopic liver transplant.
Back to article page